Overview

Effect of Berberine for Endothelial Function and Intestinal Microflora in Patients With Coronary Artery Disease

Status:
Active, not recruiting

Trial end date:
2020-12-30

Target enrollment:

Participant gender:

Summary

The purpose of this study is to conduct a single-center, randomized, open-label, controlled, dose-escalating, parallel-group study, evaluating the effects and change of endothelial function and gut microbiota after berberine administration in patients with stable coronary artery disease who are at > 8 but ≤ 40 weeks after elective percutaneous coronary intervention

Phase:

Phase 1/Phase 2

Details

Lead Sponsor:

Peking Union Medical College Hospital

Treatments:

Aspirin
Atorvastatin
Clopidogrel
Rosuvastatin Calcium